Clinical Trials Management

BC-1520 Level 1 Pharmaceuticals & Life Sciences 6 providers 13 API surfaces

Planning, execution, monitoring of clinical studies.

Clinical Trials Management (BC-1520) is a level-1 business capability in the Pharmaceuticals & Life Sciences model. The catalog holds 13 API surface(s) from 6 provider(s) that can perform some part of it. Reach is the vendor surface that lands on this capability — it is not a claim about what any particular organisation has deployed.

Where this capability definition comes from. This capability is part of a published business-architecture model that API Evangelist did not author. It is redistributed here under CC-BY-4.0. Turbo EA Capabilities by Vincent Verdet — Turbo EA, https://github.com/vincentmakes/turbo-ea-capabilities, CC BY 4.0 Changes: Consolidated from 333 per-L1 YAML files into one JSON; English only (upstream i18n/ omitted); descriptions whitespace-normalised. No capability was added, removed, renamed or re-parented. Source repository · NOTICE and third-party framework attributions

Sub-capabilities

Clinical Trial Design Management BC-1520.10

Protocol design, statistical methodology, endpoints.

no catalog coverage

Clinical Trial Site Management BC-1520.20

Site selection, activation, oversight.

2 providers, 2 API surfaces

Clinical Trial Subject Management BC-1520.30

Recruitment, screening, retention, informed consent.

1 provider, 1 API surface

Clinical Data Management BC-1520.40

EDC, data capture, query management, database lock.

1 provider, 5 API surfaces

Clinical Trial Monitoring Management BC-1520.50

Site monitoring, risk-based monitoring, audits.

no catalog coverage

Clinical Trial Supply Management BC-1520.60

IMP supply, distribution, randomisation, drug accountability.

no catalog coverage

Clinical Outsourcing & CRO Management BC-1520.70

CRO selection, contracting, oversight.

no catalog coverage

Providers that reach this capability

Ordered by rating band. Reach means a provider publishes an API surface that can perform some part of this capability — it is not a claim that any particular organisation has deployed it.

Developing 1 Usable, with meaningful gaps to close
Cancer.govTrials1 API50.0
Thin 3 Limited public surface area
National Institutes of Health (NIH)Studies1 API37.7CastorData ExportFieldsInstitutesParticipants8 APIs37.4United States National Library of MedicineStudies1 API36.8
Emerging 2 Early or largely undocumented
Life SciencesStudies1 API26.0ADARx Pharmaceuticalsclinics1 API22.0
This page carries no rating. Capabilities are not rated. A capability is a description of what a business does, not a thing a company publishes, so a Kin Score would have nothing to measure.
The edge table is a Pro feature. This page shows which providers and tags reach Clinical Trials Management. The underlying tag → capability edges — each with the quoted fragment of the provider's own OpenAPI that evidences it, a calibrated confidence score, and the contract-provenance gate it passed — are available through the API, along with company-level capability maps. Only edges at confidence ≥ 0.7 with evidence found verbatim in the source contract are published at all.

See plans →  ·  How the edges are graded →